Cardiac output measured by rebreathing nitrous oxide for the follow-up of patient with pulmonary hypertension

G. Deboeck, R. McKenzie Ross, J. Pepke-Zaba (Papworth, United Kingdom)

Source: Annual Congress 2011 - Treatment of pulmonary hypertension
Session: Treatment of pulmonary hypertension
Session type: Thematic Poster Session
Number: 2390
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Deboeck, R. McKenzie Ross, J. Pepke-Zaba (Papworth, United Kingdom). Cardiac output measured by rebreathing nitrous oxide for the follow-up of patient with pulmonary hypertension. Eur Respir J 2011; 38: Suppl. 55, 2390

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Modified exhaled nitric oxide measurement in monocrotaline-exposed rats to monitor pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms, animal models and experimental treatments
Year: 2012

The effect of inhaled nitric oxide on the cardiac performance in patients with hypoxic pulmonary hypertension
Source: Eur Respir J 2003; 22: Suppl. 45, 269s
Year: 2003

Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011

Is cardiac output assessed by inert gas rebreathing technique predictive of mortality in pulmonary hypertension?
Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension
Year: 2020


Prognostic value of end-tidal partial pressure of carbon dioxide during cardiopulmonary exercise test in pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

Haemodynamic testing in primary pulmonary hypertension - effects of nitric oxide, iloprost and oxygen
Source: Eur Respir J 2001; 18: Suppl. 33, 414s
Year: 2001

Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Arterial stiffness in COPD patients is associated with hypoxemia and plasma nitric oxide level
Source: Annual Congress 2007 - COPD and comorbidity
Year: 2007


Lung cGMP release subsequent to NO inhalation in pulmonary hypertension: responders versus nonresponders
Source: Eur Respir J 2002; 19: 664-671
Year: 2002



Non-invasive measurement of stroke volume using an inert gas rebreathing device in patients with pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2011; 39: 119-124
Year: 2012



Diagnosis of CTEPH versus IPAH using capillary to end-tidal carbon dioxide gradients
Source: Eur Respir J 2012; 39: 119-124
Year: 2012



Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008

Comparison of single-breath and tidal breathing exhaled nitric oxide levels in infants
Source: Eur Respir J 2004; 23: 369-372
Year: 2004



Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension
Source: Eur Respir J 2005; 26: Suppl. 49, 268s
Year: 2005

Feasibility of home treatment with inhaled nitric oxide for primary pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 598s
Year: 2002

Relationship between basal and nitroglycerin (GTN)-induced exhaled nitric oxide (eNO) and oxygenation parameters in ventilated patients undergoing cardiopulmonary bypass (CPB)
Source: Eur Respir J 2004; 24: Suppl. 48, 264s
Year: 2004

The relationship of systolic pulmonary arterial pressure with pulmonary function test and the fractional exhaled nitric oxide level in Kyrgyz population.
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019

Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2007; 29: 944-950
Year: 2007



Fractional exhaled nitric oxide in pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016